NORTHERN IRELAND
sciences ecosystem where companies can grow and expand. Today, the region has a strong reputation in the
sector, with expertise across a range of specialisms, including Precision Medicine, Medical Devices, Diagnostics, Clinical Trials and Data Analytics. It’s vibrant cluster of 250+ businesses, which are a mix of international investors and indigenous companies such as Almac and Randox, continue to grow and prosper in the region. In fact, some of the world’s leading medical and life science companies have invested in Northern Ireland in recent years, including Terumo, Stryker, G&L Scientific and TEVA Pharmaceutical Industries – a testament to the region’s compelling proposition. The cluster also includes highly innovative small and medium-sized enterprises, including Axial 3D, Armstrong Medical, Cirdan Imaging, Cumulus Neuroscience, Intelesens, Neurovalens, TruCorp, and Trimedika.
Looking to the Future With strong government support for life sciences and health innovation, the Health Innovation Research Alliance Northern Ireland (HIRANI) was established in 2021 to drive collaboration. By bringing Queen’s University Belfast, Ulster University and key Northern Ireland private and public partners together, this alliance acts as both a ‘one voice’ and ‘front door’ to Northern Ireland’s life and health sciences sector.
In
addition, both national and local government authorities are highly committed to promoting the life and health sciences industry in Northern Ireland. Recent government investment includes £1.3 billion investment, through City and Growth
deals, with over £140 million earmarked for future opportunities for healthcare in the region. These investments will create global centres of
innovation and provide opportunities for businesses located both in and outside Northern Ireland to collaborate and tap into the world-leading expertise of the region’s universities to create breakthrough technologies, products and services.
Access to Great Britain (GB) and the EU markets Following the UK’s exit from the European Union (EU), Northern Ireland continues to have access to the Great Britain and EU markets for goods. This means that Northern Ireland is a gateway
for the sale of goods to two of the world’s largest markets and the only place where businesses can operate free from customs declarations, rules of origin certificates and non-tariff barriers on the sale of goods to both GB and the EU. It also offers unrivalled access to both US and Asia. Medical and medical device manufacturers based in Northern Ireland can service GB and EU markets, recalibrate supply chains and design, develop and sell products, with Northern Ireland maintaining regulatory alignment on goods with the EU. Demand for new and improved pharmaceuticals and medical devices continues to grow exponentially worldwide. Still, life sciences companies face significant challenges in meeting that demand, including supply chain issues, government regulation and delays in research and manufacturing. However, Northern Ireland offers solutions for life sciences companies to take their products from research to clinical trials – through development, manufacturing and distribution. Coupled with government support, university innovation, manufacturing excellence, and a cluster of thriving life and health science companies, Northern Ireland is truly a location to consider.
Find out more information on the Life and Health Sciences sector in Northern Ireland:
www.investni.com/life-and-health-sciences
DUSSELDORF 2022 UKHEALTHCARE P A VILION. COM 15
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
